CD73 Inhibits cGAS–STING and Cooperates with CD39 to Promote Pancreatic Cancer
Célia Jacoberger-Foissac(Institute for Research in Immunology and Cancer), John Stagg(Institute for Research in Immunology and Cancer), Isabelle Cousineau(Institute for Research in Immunology and Cancer), Benjamin Haibe‐Kains(University of Toronto), Andrew C. Lake(BioSurfaces (United States)), Ricard Masia(BioSurfaces (United States)), Simon Turcotte(Centre Hospitalier de l’Université de Montréal), Sandra Pommey(The University of Melbourne), Nouredin Messaoudi(Europe Hospitals), Yacine Barèche(Institute for Research in Immunology and Cancer), Heewon Seo(Seoul National University), Simon C. Robson(Beth Israel Deaconess Medical Center), Yannic McNicoll(Hôpital de l'Enfant-Jésus), Secil Koseoglu(BioSurfaces (United States)), Neha Rohatgi(Roche (Canada)), Pavel Chrobák(Institute for Research in Immunology and Cancer), Christopher Eeles(University Health Network), Bertrand Allard(Groupe d'Oncologie Radiothérapie Tête et Cou), David Allard(Institute for Research in Immunology and Cancer), Geneviève Soucy(Centre Hospitalier de l’Université de Montréal)
Cited by 74
Related Papers
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k
Negative feedback control of neuronal activity by microglia
|Nature|2020|997
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
|Purinergic Signalling|2006|928
The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets
|Immunological Reviews|2017|901
Purinergic Signaling during Inflammation
|New England Journal of Medicine|2012|703